MAISi

AQ Platform is clinical research management software for NHS trusts, investigator sites, clinical trials units, site networks, CROs, sponsors and academic research teams. Its modules cover trial management, electronic trial and investigator site files, pharmacy and laboratory workflows, quality management, CAPA, and digital delegation of authority. Shared governed trial records and audit trails connect study operations. Connected Intelligence uses AI to flag gaps and draft next steps; a named user confirms each proposal, and customer data is not used to train models. Hosted in Microsoft Azure UK regions, the platform is designed around ICH E6(R3) and MHRA GCP inspection expectations. AQ Trials holds NHS DSPT Standards Met (2026) and Cyber Essentials certification. Phase 1 trial doctors built it; modules can be deployed individually, and it has been in daily NHS use since 2020.

Science 37 is a clinical research company specializing in decentralized clinical trials through its Metasite model, which eliminates physical proximity as a barrier, enabling patients to participate from anywhere. This approach expands access to over 90% of patients who are unable to participate in traditional site-based research, offering the recruiting power of 20 sites in one and providing the flexibility patients need to participate from anywhere. The Metasite is powered by a proprietary platform that drives uniform study orchestration, guiding the workflow of patients and study staff, and capturing study data without the need for manual reentry. This centralization of people, processes, and platforms delivers built-in protocol compliance, ensuring greater compliance and high-quality data. Science 37's in-house medical teams, telemedicine investigators, and mobile nurses have extensive experience in remote trial conduct across various therapeutic areas, ensuring broad reach.